Sweden· SE-20090224000713

Hypermin Tablett

A medicinal product containing dry extract from fresh st. john's wort, registered in Sweden by Svenska Bioforce AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedHypermin TablettATC—REGISTER NO.SE-20090224000713PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Dry Extract From Fresh St. John's Wort
Manufacturer
Svenska Bioforce AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20090224000713

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2a22b1c1-e0c6-45d9-94ab-d8b18f3fe346
GET /v1/drugs/2a22b1c1-e0c6-45d9-94ab-d8b18f3fe346?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC",
    "PAR"
  ],
  "se_npl_id": "20090224000713",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20090224000713",
  "product_doc_link": "https://docetp.mpa.se/LMF/Hypermin%20tablet%20OTC%20SmPC_09001bee807a3a24.pdf"
}

See everything about dry extract from fresh st. john's wort.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.